Published Date:2022-05-02 Original Link:https://www.onenessbio.com/en/news_detail163_2.htm No 1 Date of announcement 2022/05/02 Time of announcement 20:10:48 Subject Oneness received the notification by the international CRO on the unblinded data of FB825 Phase 2a study in moderate-to-severe atopic dermatitis in the U.S. To which item it meets paragraph 10 Date of events 2022/05/02 Statement Product:FB825 Anti-CεmX monoclonal antibody...Read More
Published Date:2022-04-18 Original Link:https://www.onenessbio.com/en/news_detail160_3.htm No 1 Date of announcement 2022/04/18 Time of announcement 19:11:58 Subject The Food and Drug Administration–Philippines (PFDA) has accepted the NDA application of the diabetic foot ulcer new drug, Fespixon To which item it meets paragraph 10 Date of events 2022/04/18 Statement Product:ON101 Diabetic foot ulcer new drug Mass production date:NA...Read More
Published Date:2022-04-11 Original Link:https://www.onenessbio.com/en/news_detail159_3.htm No 1 Date of announcement 2022/04/11 Time of announcement 17:24:47 Subject Oneness Biotech has been invited to present at the “11th Taiwan CEO Week” online investor’s conference co-organized by TWSE and QIC To which item it meets paragraph 12 Date of events 2022/04/13 Statement Date of institutional investor conference:2022/04/13~2022/04/14 Time of...Read More
Published Date:2022-04-08 Original Link:https://www.onenessbio.com/en/news_detail158_3.htm No 2 Date of announcement 2022/04/08 Time of announcement 18:13:27 Subject Oneness Biotech Co., Ltd. receives ISO13485 Medical Devices Quality Management System Certificate. To which item it meets paragraph 53 Date of events 2022/04/08 Statement Date of occurrence of the event:2022/04/08 Company name:ONENESS BIOTECH CO., LTD. Relationship to the Company (please...Read More
Published Date:2022-04-08 Original Link:https://www.onenessbio.com/en/news_detail157_3.htm No 1 Date of announcement 2022/04/08 Time of announcement 17:08:39 Subject Oneness re-announces the Board of Directors resolved to convene the Annual Shareholders’ Meeting of 2022. (Method of convening the meeting: hybrid shareholders’ meeting) To which item it meets paragraph 17 Date of events 2022/04/08 Statement Date of the board of...Read More
Published Date:2022-03-25 Original Link:https://www.onenessbio.com/en/news_detail155_3.htm No 1 Date of announcement 2022/03/25 Time of announcement 17:17:42 Subject Oneness announces the information about the investor’s conference of 2022 Q1. To which item it meets paragraph 12 Date of events 2022/03/30 Statement Date of institutional investor conference:2022/03/30 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference:Online Investor...Read More
Published Date:2022-03-18 Original Link:https://www.onenessbio.com/en/news_detail153_3.htm No 1 Date of announcement 2022/03/18 Time of announcement 17:09:16 Subject Oneness Biotech Co., Ltd. receives an Indonesian patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2022/03/18 Statement Date of occurrence of the event: 2022/03/18...Read More
Published Date:2022-03-15 Original Link:https://www.onenessbio.com/en/news_detail154_3.htm No 3 Date of announcement 2022/03/15 Time of announcement 18:10:33 Subject The Board of Directors resolved not to distribute dividends. To which item it meets paragraph 14 Date of events 2022/03/15 Statement Date of the board of directors resolution: 2022/03/15 Year or quarter which dividends belong to : 2021 Period which...Read More
Published Date:2022-03-15 Original Link:https://www.onenessbio.com/en/news_detail152_3.htm No 3 Date of announcement 2022/03/15 Time of announcement 18:47:21 Subject Oneness Nanchou manufacturing site received GMP certificate from the FDA Philippines To which item it meets paragraph 53 Date of events 2022/03/15 Statement Date of occurrence of the event: 2022/03/15 Company name: Oneness Biotech Co., Ltd. Relationship to the Company...Read More
